lymph node biopsies, 1 bone marrow biopsy, and cells derived from a malignant pleural effusion. Karyotypic analysis revealed the chromosomal translocation t(8; 14)(q24;q32) in all 9 cases. Patients were human immunodeficiency virus-negative and included 6 boys and 3 girls with an age range of 5~18 years.
Control cells consisted of cultured BL cell lines Raji (containing 50-60 EBYepisomes) [6] , P3HR-l clones 5 and 16 (EBV WZhet DNA-positive and -negative, respectively; provided by G. Miller, Yale University, New Haven, CT) [7] , Akata [8] , and EBV-infected Iymphoblastoid cell lines B95-8 [9] and 184 [10] .
Immunofluorescence and immunoblotting for viral antigens. Frozen sections of tumors fixed in 1:I methanol and acetone were examined by indirect immunofluorescence by standard procedures [II, 12] for the EBV latent protein EBNAI and lytic protein BZLFI (first leftward open-reading frame [ORF] of the BamHI Z fragment ofEBV DNA). EBNA I expression was determined using pooled monoclonal antibodies 3E4 and 4D3 [13] and a well-characterized polyclonal human serum (IT) containing antibodies to latent EBV proteins [14] . The monoclonal antibody BZ.l (gift of L. S. Young, University of Birmingham, UK) [12] was used to detect BZLFI.
For immunoblotting, cells were lysed in SDS-PAGE sample buffer containing 10% ,B-mercaptoethanol. Samples were sonicated, electrophoresed on SDS-polyacrylamide gels (8.5% for EBNA I; 10% for BZLF1), and transferred to polyvinylidene fluoride membranes (Millipore, Bedford, MA) using a semidry electroblotter (Bio-Rad, Richmond, CA). To detect EBNAl, blots blocked in 5% milk were incubated for 12 h with protein Ap urified antibody from EBV-positive human serum and probed with 1 /-lCi of 125I-labeled protein A (NEN, Boston) for 30 min. For BZLFI detection, antibody BZ.I was used at I: 1000 dilution, and binding was detected by chemiluminescence per manufacturer's recommendation (ECL kit; Amersham, Little Chalfont, UK). Wand Z probes detected standard 3.0-and 1.8-kb fragments, respectively, in tumor 8, tumor 7, and control B95-8 virus. Tumor 9 contained abnormal-sized fragments (arrows) consistent with recombination. DNA from tumors I, 3, and 5 is representative of 6 tumors that did not hybridize to any probe. Molecular weight markers (kb) are at left. [15] . 32P_Iabeled probes were derived from cloned EBV fragments spanning representative segments throughout the length ofthe viral
(random primed DNA labeling kit; Boehringer Mannheim, Indianapolis) [16] . The molecular configuration of EBV termini was determined by the method of Raab-Traub and Flynn [17] , using riboprobes to regions of unique DNA (XhoIa and the BamHI J portion of £CoRI I) flanking EBV's terminal repeats. T7 RNA polymerase (Promega, Madison, WI) was used to incorporate 32p into RNA templates of EBV DNA restriction fragments cloned into pGEM2 vector [18] . The integrated optical density of bands was quantitated with an image analysis system (Visage 110; BioImage Products, Ann Arbor, MI). (peR) analysis. PCR amplification was done on 10, 100, and 800 ng of total cellular DNA with Taq polymerase for 25-35 cycles on a DNA Thermal Cycler (Perkin-Elmer Cetus, Norwalk, CT) as described [19] . Primers were selected that framed the junction of rearranged DNA in WZhet EBV (5'-GCACATTAG-CAATGCCTGTG-3' and 5'-GTCCAGCGCGTTTACGTAAG-3'; base coordinates 1381 and 1649, respectively) [20] or were specific to regions within the BZLFI ORF (5' -AGTGGTTTCCTTG-TACGTCG-3' and 5'-TCCCAGTCTCAGACATAACC-3'; base coordinates 750 and 954, respectively) [20] . PCR products electrophoresed in a 3% NuSieve/l % Seakem agarose gel (FMC Bioproducts, Rockland, ME) were hybridized after Southern transfer to 32P_Iabeled probes specific for sequences internal to the primers.
Detection of EBV DNA rearrangements by polymerase chain reaction

Results
Molecular corifiguration ofEBV DNA in sporadic BL tumor tissue. The structure ofEBV termini has been used to provide evidence for clonality of EBV neoplasms, to indicate viral integration, and to suggest the state of viral activation in cells: replicating (linear configuration) versus latent (circular forms) [17] . Restriction endonuclease digestion of EBV DNA with BamBI preserves the terminal repeat sequences, which vary in number with each virus isolate, but cleaves flanking unique DNA. In EBV's episomal configuration, fused terminal sequences provide a band of higher molecular weight than single unjoined ends of the linear EBV genome. Clonal expansion of one cell carrying a single virus can be distinguished from an oligoclonal or polyclonal lymphoproliferative process involving mixed populations of EBY genomes, each with distinct numbers of terminal repeats, by the detection of single versus multiple high-molecular-weight episomal bands.
With this approach, tumor DNA was examined for EBY episomes characteristic of virus-associated lymphomas. When Southern blots of BamHI-digested cellular DNA were hybridized to riboprobes specific to the left and right termini of EBY, only one (no. 7) of9 tumor DNAs contained EBY (figure lA). As with the Raji cell control [17] , single and intense highmolecular-weight bands of equal size indicated tumor clonality and presence of multiple copies of a uniform EBY episome. In contrast to this result, preliminary PCR screening for sequences specific to the Bam HI Z fragment of EBY DNA showed virus in 4 of 9 tumor DNAs: 3 lymph node biopsies (nos. 7-9) and 1 pleural effusion (no. 1) (data not shown).
Because integrated fragments of viral DNA have been detected in the absence of the complete viral genome after in vitro B cell infection [21] , we probed blots for EBY sequences internal to viral termini. With probes specific for EBY DNA fragments BamHI Wand Z (figures IB and 2), intense hybridization signals were obtained with DNA from tumor 7, consistent with its multiple episomal copy number. However, in 2 additional tumors (nos. 8 and 9), low-intensity bands « 1 genome equivalent/cell) were detected: one had appropriately sized restriction fragments, while the second revealed bands of abnormal size (arrows, figure IB), suggesting intragenomic rearrangements or recombination of Wand Z fragments with cellular DNA.
Hybridizations with probes spanning much of the EBY genome are summarized in figure 2. The tumor with episomal EBY DNA (no. 7) contained normal-sized restriction fragments, consistent with the presence of the standard EBY genome. Analysis of tumor 8 also indicated presence of the standard viral genome except for DNA deletions at each terminus. Absence of the BamHI C fragment at the left end and evidence for an abnormally sized 10-kb EcoRl C fragment on the right end are consistent with integration of EBY into cellular DNA at those sites (figure 2). A third tumor (no. 9) contained not only the abnormal BamHI Wand Z fragments (figure IB) but also a single 7.5-kb band when hybridized to the EcoRI C probe, which normally spans 5 Bam HI fragments in the B95-8 prototype virus (see restriction map, figure 2) . Last, the tumor DNA derived from pleural effusion (no. 1), identified as EBYpositive by PCR screening, did not hybridize in Southern blot analyses.
Defective EB V genome that disrupts latency. Rearrangements ofEBY DNA, called heterogeneous (het) DNA [23, 24] , are found in a defective viral genome known to activate the EBY lytic replication cycle [25] [26] [27] . The intragenomic rearrangement results in the constitutive expression of the BZLFI protein [28] , a transcriptional transactivator [29, 30] that has also been shown to bind the cellular tumor suppressor protein, p53 [31] . To determine if abnormally sized Wand Z EBY DNA fragments shown here were juxtaposed with inversion of the BZLFI ORF typical of WZhet [20, 24] , we used PCR primers to flank the aberrant junction of the two DNA fragments, separated by 55 kb in standard EBY. Of the 9 tumors, 2 (nos. I and 9) contained rearranged WZhet DNA as evidenced by PCR products that hybridized to both Z-and Wspecific oligonucleotide probes (figure 3). WZhet DNA sequences were not detected in the remaining 7 patient samples figure 3) .
Expression of viral proteins. Of 9 tumors, only the specimen that contained EBV episomes expressed EBNAI when examined by immunofluorescent staining and immunoblot techniques ( figure 4A, B) . Notably, tumor 8, which retained the EBNA1-encoding BamHI K DNA fragment but lacked terminal sequences that regulate latent gene expression [33] (figures 1 and 2) , did not express EBNAl. The lytic protein BZLFI was not detected in any of the 4 tumors with EBV DNA, including those containing WZhet DNA (figure 4C).
Discussion
Primary B lymphocytes immortalized by EBV harbor multiple episomal copies of the EBV genome and express six nuclear antigens and three membrane proteins, most of which have been shown to be critical for growth transformation [33] . By contrast, only EBNAI (which appears to have no intrinsic growth-enhancing potential but is required for episome maintenance) [34, 35] is expressed in virus-associated BL tumors [36] . Thus, viral genes critical to growth transformation and proliferation of primary B cells (and perhaps to initial steps of the oncogenic process) appear nonessential for maintenance of the malignant phenotype.
Our findings now suggest that the viral genome itself may be dispensable at some stage of tumor development. We detected EBV DNA evidence in 3 of 8 sporadic BL tumors that would otherwise be classified as virus-negative by standard criteria. Presence of EBV DNA in clinical samples without detectable viral antigen expression (to include EBNAl) has not been previously reported [37] . That viral sequences we identified might represent infiltration of the tumor mass with EBV-infected lymphocytes or denote secondary infection of a subset ofEBV-negative tumor cells seems unlikely. Circulating B cells carry prototype EBV genomes, heterogeneous primarily with respect to number of terminal repeats. Detection solely of integrated or rearranged WZhet viral sequences is inconsistent with either polyclonal lymphoid infiltration or de novo infection of the tumor mass with a mixed virion population and may reflect susceptibility ofEBV DNA to recombinogenic processes underlying chromosomal translocations and cellular genomic instability.
Although observed in vitro [21, [38] [39] [40] [41] , integration ofEBV into cellular DNA has been assumed to occur rarely in natural disease states [42, 43] . Our examination of sporadic BL lacking EBV episomes removed the technical difficulty of detecting a single integrated sequence against the background of a high episomal copy number and suggests an approach to a systematic search for EBV integration. Indeed, selection of cell lines specifically for low episomal copy number facilitated the demonstration of coexistent integrated EBV [44] . With increasing evidence to suggest that cellular recombination machinery is usurped for essential needs of the virus [45, 46] , EBV integra- tion and intragenomic rearrangement [43, 47] , as found in these tumors, may be patterned mechanistically after comparable cellular processes [48, 49] . The presence of WZhet EBV DNA without the prototype genome has not been previously observed in vitro [24, 25] or in vivo [19, 50, 51] . Components ofWZhet DNA, visible on Southern blot, were confirmed by separate PCR techniques that amplified sequences in the BZLFI ORF as well as across abnormally juxtaposed Wand Z fragments. Presumably dependent on standard EBV for replication [52] , the defective genome would not be maintained in cells lacking helper virus unless integrated, which the abnormally sized DNA bands (tumor 9, figure 1B) imply has occurred. Detection of the defective genome unaccompanied by standard EBV implies it is both infectious [52] and intrinsically pathogenic. Alternatively, intracellular generation of WZhet may have induced the loss of the parental virus, an interpretation consistent with the experimental reduction of EBV episomal copy number by transfection of the BZLFI gene into latently infected cells [53] . Although we could not demon-strate BZLF1 protein in the tumors examined, expression may have preceded integration.
The less-than-complete association of EBV with BL has made the virus's contribution to this disease unclear. Either factors other than EBV are responsible for tumorigenesis or, as our findings now suggest, EBV DNA may in some instances be lost after tumor initiation. Unlike other human DNA viruses, for which support for "hit-and-run" mechanisms of viral oncogenesis rests largely on negative evidence [5] , EBV has both well-known oncogenic potential and an irregular association with tumors of common histologic type. Viral DNA footprints in a subset of BL tumors expands the scope of EBV participation in this disease and implies that EBV DNA recombination and loss, previously observed in cultured lymphocytes, may also operate in human disease processes.
